Medicare Enrolled
Dr. Quoc Le, MD
Family Medicine · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Quoc Le is a family medicine in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Le performed 4,235 Medicare services across 2,155 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $17,364 from 71 pharmaceutical and/or device companies across 912 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 5% volume in TX$ $17,364 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,235
Medicare services
Top 5% in TX for family medicine
2,155
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~223 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,068 | $86 | $326 |
| Automated urinalysis | 589 | $2 | $9 |
| Chronic care management, first 20 min/month | 526 | $49 | $75 |
| Office visit, established patient (20-29 min) | 456 | $56 | $221 |
| Dexamethasone injection (steroid) | 347 | $0 | $10 |
| Annual wellness visit, follow-up | 238 | $132 | $343 |
| Drug injection, under skin or into muscle | 122 | $10 | $73 |
| Flu vaccine administration | 118 | $31 | $42 |
| Flu vaccine, high-dose | 112 | $72 | $80 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 100 | $55 | $150 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 56 | $282 | $325 |
| Pneumonia vaccine administration | 56 | $31 | $40 |
| Chest X-ray, 2 views | 53 | $25 | $60 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 50 | $33 | $60 |
| Detection test by immunoassay technique for influenza virus | 43 | $13 | $50 |
| Ceftriaxone antibiotic injection | 35 | $0 | $30 |
| New patient office visit (30-44 min) | 34 | $57 | $326 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 29 | $33 | $75 |
| Electrocardiogram (EKG), 12-lead | 27 | $9 | $51 |
| Transitional care management services for problem of at least moderate complexity | 24 | $162 | $500 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 24 | $42 | $100 |
| Administration and interpretation of patient-focused health risk assessment | 22 | $2 | $75 |
| X-ray of lower and sacral spine, minimum of 4 views | 21 | $38 | $75 |
| Injection, cefotaxime sodium, per gm | 21 | $4 | $140 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 19 | $80 | $120 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 18 | $169 | $498 |
| Blood glucose (sugar) test performed by hand-held instrument | 16 | $3 | $10 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $168 | $514 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,364
Total received (2018-2024)
Avg $2,481/year across 7 years
Top 2% in TX for family medicine
71
Companies
912
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,213 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$151 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,450
2023$2,461
2022$2,431
2021$2,790
2020$2,108
2019$2,954
2018$2,170
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,584
Novo Nordisk Inc
$2,510
Amgen Inc.
$1,352
Lilly USA, LLC
$878
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$695
PFIZER INC.
$647
Amarin Pharma Inc.
$615
GlaxoSmithKline, LLC.
$555
Astellas Pharma US Inc
$530
Boehringer Ingelheim Pharmaceuticals, Inc.
$525
SANOFI-AVENTIS U.S. LLC
$462
Bayer HealthCare Pharmaceuticals Inc.
$318
Teva Pharmaceuticals USA, Inc.
$309
AbbVie Inc.
$293
Merck Sharp & Dohme Corporation
$274
Janssen Pharmaceuticals, Inc
$271
Bayer Healthcare Pharmaceuticals Inc.
$230
Radius Health, Inc.
$205
OptiNose US, Inc.
$203
Abbott Laboratories
$197
ABBVIE INC.
$189
SANOFI PASTEUR INC.
$188
Paratek Pharmaceuticals, Inc.
$177
Biohaven Pharmaceutical Holding Company Ltd.
$176
Allergan Inc.
$166
Exact Sciences Corporation
$163
Stryker Corporation
$139
Dexcom, Inc.
$135
Optinose US, Inc.
$135
Horizon Pharma plc
$125
Esperion Therapeutics, Inc.
$125
Novartis Pharmaceuticals Corporation
$123
SHIELD THERAPEUTICS INC
$109
Hologic, LLC
$108
Merck Sharp & Dohme LLC
$103
Avanir Pharmaceuticals, Inc.
$102
AbbVie, Inc.
$100
Shield Therapeutics Inc
$93
Intuitive Surgical, Inc.
$92
JAZZ PHARMACEUTICALS INC.
$87
AIMMUNE THERAPEUTICS, INC.
$78
Sanofi Pasteur Inc.
$68
kaleo, Inc.
$55
Circassia Pharmaceuticals Inc
$52
DEXCOM, INC.
$52
Azurity Pharmaceuticals, Inc.
$51
ARBOR PHARMACEUTICALS, INC.
$49
Inspire Medical Systems, Inc.
$48
ALK-Abello, Inc
$45
SCYNEXIS, Inc.
$45
Gilead Sciences, Inc.
$44
Allergan, Inc.
$43
Phadia US Inc.
$42
Eisai Inc.
$36
Dynavax Technologies Corporation
$33
Biohaven Pharmaceuticals, Inc.
$32
Arbor Pharmaceuticals, Inc.
$31
Currax Pharmaceuticals LLC
$29
IDORSIA PHARMACEUTICALS US INC
$28
Althera Pharmaceuticals LLC
$25
Medtronic, Inc.
$23
Shire North American Group Inc
$23
Genentech USA, Inc.
$21
Hikma Pharmaceuticals USA
$19
Regeneron Healthcare Solutions, Inc.
$19
Medtronic Vascular, Inc.
$17
Inari Medical, Inc.
$15
Mission Pharmacal Company
$14
Kaleo, Inc.
$14
Orexigen Therapeutics, Inc.
$13
Xeris Pharmaceuticals, Inc.
$13
Top 3 companies account for 37.1% of total payments
Associated products mentioned in payments ›
ABRYSVO · ACCRUFER · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AUVI-Q · Aimovig · Auvi-Q · BASAGLAR · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CONTRAVE · CREON · CYCLOSET · ClosureFast · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DUPIXENT · Da Vinci Surgical System · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLOWTRIEVER CATHETER · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · GVOKE PFS · HORIZANT · Heplisav-B · Horizant · INSPIRE · INTELLIS ADAPTIVESTIM · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LINZESS · MAKO · MENACTRA · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NAMZARIC · NEXLETOL · NO PRODUCT DISCUSSED · NUEDEXTA · NURTEC ODT · NUZYRA · OCTRODE · Odactra · Otezla · Otiprio · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rinvoq · Roszet · Rybelsus · S · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · THINPREP · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · TRUMENBA · TUDORZA PRESSAIR · TZIELD · ThinPrep · Thinprep · Tresiba · Tymlos · UBRELVY · Uribel · VIBERZI · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · Xofluza · Xultophy 100/3.6 · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Equivalent to $410 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
1,587
Per 100K population
33.4
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Le is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 2%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Le performed 1,068 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $17,364 from 71 companies across 912 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other family medicines in Houston?
Dr. Le's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Houston
Browse family medicines in Houston ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology